systematic review of biomarkers associated with maternal infection in pregnant and postpartum women.

Oben AG., Johnson BM., Tita ATN., Andrews WW., Hibberd PL., Subramaniam A., Sinkey RG.

BACKGROUND: Serum biomarkers are commonly used to support the diagnosis of infection in non-pregnant patients whose clinical presentation suggests infection. The utility of serum biomarkers for infection in pregnant and postpartum women is uncertain. SEARCH STRATEGY: PubMed, CINAHL, EMBASE, ClinicalTrials.gov, Cochrane Library, CINAHL, and SCOPUS were searched from inception to February 2020. SELECTION CRITERIA: Full-text manuscripts in English were included if they reported the measurement of maternal serum biomarkers-and included a control group-to identify infection in pregnant and postpartum women. DATA COLLECTION AND ANALYSIS: two authors independently screened manuscripts, extracted data, and assessed methodologic quality. MAIN RESULTS: Interleukin-6 (IL-6), C-reactive protein, procalcitonin, insulin-like growth factor binding protein 1, tumor necrosis factor-α, calgranulin B, neopterin, and interferon-γ inducible protein 10 reliably indicated infection. Intercellular adhesion molecule 1, monocyte chemotactic and activating factor, soluble IL-6 receptor, and IL-8 were not useful markers in pregnant and postpartum women. CONCLUSIONS: Findings suggest that certain biomarkers have diagnostic value when maternal infection is suspected, but also confirms limitations in this population.

DOI

10.1002/ijgo.13747

Type

Journal article

Publication Date

2022-04-01T00:00:00+00:00

Volume

157

Pages

42 - 50

Total pages

8

Keywords

biomarkers, chorioamnionitis, maternal morbidity, maternal mortality, puerperal infection, sepsis, systematic review, Biomarkers, Female, Humans, Postpartum Period, Pregnancy

Permalink More information Close